This research suggests that women who are prescribed pre-exposure prophylaxis (PrEP) for HIV infection think differently about it, ranging from fear and avoidance to trust and advocacy for its use. The authors recommend that PrEP rollout should address beliefs and provide opportunities to talk about PrEP-related decision-making, including exploring fears and building trust in the medicine and the systems that provide it.
Experiences with HPTN 067/ADAPT study-provided open-label PrEP among women in Cape Town: Facilitators and barriers within a mutuality framework
Written By
Amico KR, Wallace M, Bekker LG, Roux S, Atujuna M, Sebastian E, Dye BJ, Elharrar V, Grant RM
